• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

证据在世界卫生组织建议中的应用。

Use of evidence in WHO recommendations.

作者信息

Oxman Andrew D, Lavis John N, Fretheim Atle

机构信息

Norwegian Knowledge Centre for The Health Services.

出版信息

World Hosp Health Serv. 2007;43(2):14-20.

PMID:17894189
Abstract

BACKGROUND

WHO regulations, dating back to 1951, emphasise the role of expert opinion in the development of recommendations. However, the organisation's guidelines, approved in 2003, emphasise the use of systematic reviews for evidence of effects, processes that allow for the explicit incorporation of other types of information (including values), and evidence-informed dissemination and implementation strategies. We examined the use of evidence, particularly evidence of effects, in recommendations developed by WHO departments.

METHODS

We interviewed department directors (or their delegates) at WHO headquarters in Geneva, Switzerland, and reviewed a sample of the recommendation-containing reports that were discussed in the interviews (as well as related background documentation). Two individuals independently analysed the interviews and reviewed key features of the reports and background documentation.

FINDINGS

Systematic reviews and concise summaries of findings are rarely used for developing recommendations. Instead, processes usually rely heavily on experts in a particular specialty, rather than representatives of those who will have to live with the recommendations or on experts in particular methodological areas.

INTERPRETATION

Progress in the development, adaptation, dissemination, and implementation of recommendations for member states will need leadership, the resources necessary for WHO to undertake these processes in a transparent and defensible way, and close attention to the current and emerging research Literature related to these processes.

摘要

背景

世界卫生组织(WHO)自1951年起的相关规定强调专家意见在制定建议过程中的作用。然而,该组织在2003年批准的指南则强调使用系统评价来获取效应证据,采用能够明确纳入其他类型信息(包括价值观)的流程,以及基于证据的传播和实施策略。我们研究了WHO各部门在制定建议时对证据的使用情况,尤其是效应证据。

方法

我们采访了位于瑞士日内瓦的WHO总部各部门主任(或其代表),并审查了采访中讨论的包含建议的报告样本(以及相关背景文件)。两名研究人员独立分析了采访内容,并审查了报告和背景文件的关键特征。

研究结果

系统评价和研究结果的简要总结很少用于制定建议。相反,相关流程通常严重依赖特定专业领域的专家,而非那些将遵循这些建议的人群的代表或特定方法学领域的专家。

解读

要在为成员国制定、调整、传播和实施建议方面取得进展,需要领导力、WHO以透明且合理的方式开展这些流程所需的资源,以及密切关注与这些流程相关的现有和新出现的研究文献。

相似文献

1
Use of evidence in WHO recommendations.证据在世界卫生组织建议中的应用。
World Hosp Health Serv. 2007;43(2):14-20.
2
Use of evidence in WHO recommendations.证据在世卫组织建议中的应用。
Lancet. 2007 Jun 2;369(9576):1883-1889. doi: 10.1016/S0140-6736(07)60675-8.
3
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
4
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
5
Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.介入性疼痛管理中的循证医学、系统评价和指南,第一部分:引言与一般考虑因素
Pain Physician. 2008 Mar-Apr;11(2):161-86.
6
EULAR recommendations for the management of Behçet disease.欧洲抗风湿病联盟(EULAR)关于白塞病管理的建议。
Ann Rheum Dis. 2008 Dec;67(12):1656-62. doi: 10.1136/ard.2007.080432. Epub 2008 Jan 31.
7
Implementation of evidence-based humanitarian programs in military-led missions: part I. Qualitative gap analysis of current military and international aid programs.在军事主导任务中实施循证人道主义项目:第一部分。当前军事和国际援助项目的定性差距分析。
Disaster Med Public Health Prep. 2008 Dec;2(4):230-6. doi: 10.1097/DMP.0b013e31818d3c80.
8
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update.《变应性鼻炎及其对哮喘的影响指南(2008年更新版)》的制定方法
Allergy. 2008 Jan;63(1):38-46. doi: 10.1111/j.1398-9995.2007.01560.x.
9
[EULAR recommendations for the management of Behçet's disease. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)].[欧洲抗风湿病联盟白塞病管理推荐意见。国际临床研究包括治疗学欧洲常务委员会(ESCISIT)特别工作组报告]
Z Rheumatol. 2009 Mar;68(2):157-61. doi: 10.1007/s00393-008-0407-1.
10
Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management.哌甲酯中毒:院外管理的循证共识指南
Clin Toxicol (Phila). 2007 Oct-Nov;45(7):737-52. doi: 10.1080/15563650701665175.

引用本文的文献

1
Transparency: A central principle underpinning trustworthy guidelines.透明度:信任准则的核心原则。
J Clin Epidemiol. 2022 Feb;142:246-248. doi: 10.1016/j.jclinepi.2021.11.025. Epub 2021 Nov 16.
2
Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review.影响医疗保健专业人员临床指南实施的因素:一项系统性的元综述。
BMC Med Inform Decis Mak. 2008 Sep 12;8:38. doi: 10.1186/1472-6947-8-38.
3
Using participatory design to develop (public) health decision support systems through GIS.
利用参与式设计通过地理信息系统开发(公共)卫生决策支持系统。
Int J Health Geogr. 2007 Nov 27;6:53. doi: 10.1186/1476-072X-6-53.